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It is becoming a consensus that white matter integrity is compromised in schizophrenia
(SZ), however the underlying genetics remains elusive. Evidence suggests a polygenic
basis of the disorder, which involves various genetic variants with modest individual effect
sizes. In this work, we used a multivariate approach, parallel independent component
analysis (P-ICA), to explore the genetic underpinnings of white matter abnormalities in
SZ. A pre-filtering step was first applied to locate 6527 single nucleotide polymorphisms
(SNPs) discriminating patients from controls with a nominal uncorrected p-value of 0.01.
These potential susceptibility loci were then investigated for associations with fractional
anisotropy (FA) images in a cohort consisting of 73 SZ patients and 87 healthy controls
(HC). A significant correlation (r = −0.37, p = 1.25 × 10−6 ) was identified between one
genetic factor and one FA component after controlling for scanning site, ethnicity, age, and
sex. The identified FA-SNP association remained stable in a 10-fold validation. A 5000-run
permutation test yielded a p-value of 2.00 × 10−4 . The FA component reflected decreased
white matter integrity in the forceps major for SZ patients. The SNP component was
overrepresented in genes whose products are involved in corpus callosum morphology
(e.g., CNTNAP2, NPAS3, and NFIB) as well as canonical pathways of synaptic long term
depression and protein kinase A signaling. Taken together, our finding delineates a part of
genetic architecture underlying SZ-related FA reduction, emphasizing the important role of
genetic variants involved in neural development.
Keywords: diffusion tension imaging (DTI), fractional anisotropy (FA), parallel independent component analysis
(P-ICA), single nucleotide polymorphisms (SNPs), schizophrenia

INTRODUCTION
Schizophrenia (SZ) is a severe, debilitating mental disorder
with heritability estimated up to ∼80% (Sullivan et al., 2003).
However, its genetic basis remains elusive. The last decade has
seen a large number of genome wide association studies (GWAS)
searching for genetic variants regulating the liability for SZ
(Gejman et al., 2011). More recently, very large sample sizes
have been made possible with aggregated data through collaborative consortia, yielding more reliable and replicable findings
(Visscher et al., 2012). Indeed, evidence accumulates to suggest
the polygenicity of SZ, where genetic variants with subtle effects
may function together to confer the liability (Purcell et al., 2009,
2014; Giusti-Rodriguez and Sullivan, 2013). One estimation is
that, together, genome-wide SNPs capture 23% of the variation
in SZ liability, a substantial portion of which is due to common
variants (Lee et al., 2012). Obviously, the combined effect of multiple variants is more prominent than those of individuals SNPs
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and hence more likely to be identifiable. In this sense, multivariate approaches assessing multiple variables for aggregate effects
appear to be better positioned for modeling the polygenic basis
of SZ.
Given the complexity and heterogeneity of SZ, one valuable
strategy to unravel the genetic risk is through investigating the
effects of genetic variants on intermediate phenotypes such as disrupted brain structure and function, which are more proximal to
biological mechanisms compared to behavioral measures (Rose
and Donohoe, 2013). In the last two decades notable progress
has been made in mapping gray matter abnormalities in SZ.
The investigation of white matter integrity was lagging behind
until the advancement in magnetic resonance diffusion imaging
(MR-DI) technique affords characterizing fiber tract direction
and organization. One can model these data with a single tensor model in which a diffusion tensor is estimated for water
molecules at each voxel to derive metrics of anisotropy which
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infer fiber properties and can be compared across subjects for
associations with other traits of interest. With this technique and
more complex multiple tensor or diffusion spectrum imaging
techniques applied to SZ studies, there is consensus that white
matter integrity is compromised in affected patients, including
decreased fractional anisotropy (FA) in prefrontal and temporal lobes, as well as the fiber bundles connecting these regions
(Kubicki et al., 2007). In addition, family studies further showed
a genetic factors might underlie the FA deficits, which were
also observed, with a lower extent, in unaffected relatives of
patients (Hoptman et al., 2008; Maniega et al., 2008; Clark et al.,
2011).
These previous findings strongly indicate FA deficits as a heritable biomarker for SZ. However, to our knowledge, there has
not been enough work characterizing the genetic aspects, and
this is what motivated the current study. We studied 73 SZ
patients and 87 controls with good-quality genome-wide SNP
data and FA images. A pre-filtering step was applied to locate
SNPs which show a weak differentiation of patients from controls.
These potential causal loci were then analyzed for associations
with FA images using parallel independent component analysis
(P-ICA) (Liu et al., 2009; Liu and Calhoun, 2014). As a multivariate approach, P-ICA extracts genetic and imaging components,
respectively from the SNP data and FA images to capture clusters of SNPs or voxels exhibiting co-variations across subjects
which simultaneously emphasizing imaging-genetic associations
in order to identify genetic factors explaining FA variation. This
approach also enables us to study genetic variants clustered into
components at a pathway level, potentially providing more insight
into the underpinnings of SZ. To guard against false discoveries,
the identified FA-SNP associations were evaluated with 10-fold
validation and permutation tests.

MATERIALS AND METHODS
PARTICIPANTS

The Mind Clinical Imaging Consortium (MCIC), a collaborative effort of four research teams from New Mexico (NM),
Boston (MGH), Iowa (IOWA), and Minnesota (MINN) was
involved in subject recruitment and data collection (Gollub
et al., 2013). The number of healthy controls/patients with
schizophrenia were balanced and matched for age/gender as
much as possible. Only participants having good quality DTI
and GWS data were considered. Each site’s institutional review
board approved the study and all the participants provided
written informed consents. Healthy participants were screened
to ensure that they were free of any neurological, medical or
psychiatric illnesses, including any history of substance abuse.
Structured clinical interviews for DSM-IV (SCID) and case file
reviews confirmed a diagnosis of schizophrenia for the patients
(Williams et al., 1992). A total of 160 participants who had
volunteered for DTI and gene testing were included in this
work, including 73 SZ patients and 87 healthy controls (see
Table 1 for demographic information). We admitted all ethnic
groups (self-reported) to maximize the sample size. Ethnicity
information was missing for eight participants but was inferred
based on the genetic data using principal component analysis
(PCA).
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Table 1 | Demographic information of patients with schizophrenia
and healthy controls.
Demographics
Sex
Age
Ethnicity

SZ (73)

HC (87)

Male

54

51

Female

19

36

34 ± 11

32 ± 11

Mean ± SD
Caucasian

53

81

Asian

5

3

American Indian or Alaska Native

1

0

African-American

14

3

DTI IMAGE ACQUISITION AND PREPROCESSING

The image acquisition parameters are summarized in Table 2
(White et al., 2011). Prior to diffusion tensor calculation, images
went through standard preprocessing (Caprihan et al., 2011).
DTI preprocessing included three steps: (1) Data quality check:
Subjects with signal dropouts caused by motion or presence of
striated artifacts on images were not included in the study. (2)
Motion and eddy current correction: We registered all the images to
a b =0 sec/mm2 image. Twelve degrees of freedom, affine transformation with mutual information cost function was used for
image registration. (3) Adjusting the diffusion gradient direction:
Two corrections were applied to the diffusion gradients. The
nominal diffusion gradient directions were prescribed in the magnet axis frame. We rotated them to correspond to the image slice
orientation. No correction was required if the imaging slice was
pure axial. A second correction accounted for any image rotation
during the previous motion and eddy current correction step.
The rotation part of the transformation found previously was
extracted, and each gradient direction vector corrected accordingly. All the image registration and transformations were done
with the FLIRT (FMRIB’s Linear Image Registration Tool) program [FMRIB Software Library (FSL); www.fmrib.ox.ac.uk/fsl].
Dtifit, a tool in FSL, was adopted to calculate the diffusion tensor and the fractional anisotropy (FA) maps. The FA image was
aligned to a MNI FA template with a non-linear registration algorithm FNIRT (FMRIB’s Non-linear Image Registration Tool; FSL)
and resliced via SPM resulting in a final voxel size of 2 × 2 ×
2 mm. After preprocessing, the FA maps were smoothed using
8 mm smoothing kernel (Jones et al., 2005).
We noticed significant differences in data collected at one site,
which might be related to a cohort effect or greater variability
due to fewer DTI directions. With site coded as dummy variable,
we performed a voxelwise regression on FA images using Matlab,
thereby eliminating the site effects. Site-by-diagnosis interactions
were checked post-hoc after P-ICA decomposition using the FA
loadings.
SNP DATA COLLECTION AND PREPROCESSING

The genotyping and genetic quality control procedures were
same as described in our previous work (Chen et al., 2012b),
which is briefly discussed here. DNA was extracted from a blood
sample collected at individual sites. Genotyping for all subjects was performed at the Mind Research Network using the
Illumina Infinium Human Omni1-Quad assay spanning a total of
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Table 2 | DTI acquisition parameters at four sites for MCIC study.
Scanning parameter
Scanner (Tesla)

Site 1

Site 2

Site 3

Site 4

Siemens (1.5)

GE Signa (1.5)

Siemens Trio (3)

Siemens (1.5)

TR (ms)

9500

8900

10,500

9800

TE (ms)

90

80

98

86

2×2×2

2 ×2 × 2

2×2×2

2×2×2

Voxel dimensions (mm)
Diffusion directions
B-values (s/mm2 )
NEX
Bandwidth (Hz/pixel)

6

60

12

12

0/1000

0/700

0/1000

0/1000

4

1

2

4

1954

1860

1342

1502

TR, repetition time; TE, echo time; NEX, number of excitations.

1,140,419 SNP loci. BeadStudio was used to make the final genotype calls and PLINK (Purcell et al., 2007) was employed for a
series of quality controls (Anderson et al., 2010) including: (a)
gender consistency check, (b) sample relatedness (not closer than
second degree relatives), (c) genotyping call rate (>90% at both
the individual and SNP level), (d) Hardy–Weinberg equilibrium
in the control population (p < 1 × 10−6 ), (e) minor allele frequency (MAF > 0.05), and (f) missing calls were replaced using
high linkage disequilibrium (LD) loci if available or otherwise
removed. A total of 777,365 SNP loci were retained after quality
control and discrete numbers were then assigned to the categorical genotypes: 0 (no minor allele), 1 (one minor allele), and 2
(two minor alleles). With PCA, two principal components were
identified as ethnicity-related and eliminated from the data. No
clear population structure was observed in the corrected data.
ALGORITHM FOR EXTRACTION OF LINKAGES IN MULTIMODAL
DATASETS

P-ICA first extracts components from the two modalities in parallel based on infomax ICA (Bell and Sejnowski, 1995), and then
enhances the correlations between pairs of components loadings.
The following Equations (1) and (2) describe the mathematical
model of Infomax. For each modality, the data are decomposed
into a linear combination of underlying components. X1 and
X2 represents the FA and SNP modalities; S1 and S2 represents
the underlying independent components, while A1 and A2 represent the mixing matrix/loadings for FA and SNP modalities; W
denotes the un-mixing matrix, which is the (pseudo) inverse of
A. Equation (3) illustrates the objective function of entropy and
correlations computed between columns of loadings matrices A1
and A2 . fy (Y) is the probability density function of Y; E is the
expected value; H is the entropy function; W0 is the bias vector.
W is then iteratively updated based on the natural gradient rule to
optimize the objective function. A full description as well as the
mathematical/simulation details of the algorithm can be found
in our previous publications (Liu et al., 2008, 2009; Chen et al.,
2012a) and the algorithm is available in the fusion ICA toolbox
(FIT) (http://mialab.mrn.org/software/fit).
W

1 = A−1
1

X1 = A1 · S1 −→ S1 = W1 · X1
W

2 = A−1
2

X2 = A2 · S2 −→ S2 = W2 · X2
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(1)
(2)





max{H (Y1 ) + H (Y2 ) + [corr (A1 , A2 )]2 } = − E lnfy (Y1 ) −



E lnfy (Y2 ) +

Y=

2 

cov A1i , A2j
 
var (A1i ) · var A2j

1
; U = WX + W0
1 + e−U

(3)

P-ICA yields best performances when the ratio of sample size to
the number of variables is above 0.02 for the genetic modality
(Liu et al., 2008). Consequently, a pre-filtering step was conducted to locate 6527 SNPs, discriminating patients from controls
with p-values less than 0.01 uncorrected. These potential susceptibility loci were then analyzed for associations with neurobiological traits. The component number was estimated to be nine
for the FA modality using minimum description length (MDL)
(Rissanen, 1978). The SNP component number was estimated
to be seven based on component consistency as in Chen et al.
(2012a). P-ICA was performed through the Fusion ICA Toolbox
(FIT, http://mialab.mrn.org/software/fit/index.html). The algorithm was configured with a threshold of 0.3 for constrained
correlations to avoid false positive associations and to only constrain one pair of components. The endurance parameter was set
to −1 × 10−5 to control the decreasing slope of the entropy term
and avoid over fitting. We performed two independent P-ICA
decompositions, one with the entire dataset (i.e., 73 Sz and 87
HC) and the second using Caucasian participants only (i.e., 53 Sz
and 81 HC). We also performed association analysis between the
FA/SNP loadings and the Positive and Negative Syndrome Scale
(PANSS) symptoms as well as medication.
PERMUTATION AND 10-FOLD CROSS VALIDATION TESTS

We performed a permutation test to assess the validity of identified FA-SNP association by investigating the occurrences of
inter-modality correlations by chance in permuted FA and SNP
datasets. The null distribution was constructed with the top correlation obtained from each test run. We then counted the instances
with correlations greater than that observed from the original
data and calculated the tail probability as the significance level. We
also performed a 10-fold cross-validation to examine the reproducibility of the identified FA-SNP association using a subset of
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90% subjects. The same P-ICA parameters were used for all subset
P-ICA decompositions.

RESULTS
P-ICA identified one FA-SNP pair components presenting a significant correlation (r = −0.37, p = 1.25 × 10−6 ) and passing
the Bonferroni threshold of 7.93 ×10−4 , after controlling for
age/sex and correcting for 63 independent tests. The FA-SNP
pair replicated in all 10-fold validations having a correlation
range of 0.18–0.46 and a median of 0.33. The FA and SNP
components identified in subset decompositions in 10-fold crossvalidation showed similar patterns to those identified with the
entire dataset. The overlapping ratio refers to the percentage
replication of the associated SNP component from the entire
dataset with the associated SNP component in various subset
decompositions. The overlapping ratio was around 50–70% in
the various subset decompositions. Though variability existed
in SNP component from entire dataset and subset decompositions, the genes/pathways obtained were very similar. Hence
the final set of associated SNPs was selected from the results of
entire dataset. In a 5000-run permutation test, the absolute values of FA-SNP top correlations ranged from 0.11 to 0.43 with
a median of 0.19, yielding a p-value of 2.00 × 10−4 and passing
the Bonferroni threshold of 7.93 × 10−4 for the identified association. We further examined the FA-SNP association within the SZ
and HC groups, respectively, and observed a partial FA-SNP correlation of −0.1304 (p = 0.27) within the schizophrenia patients
and −0.0019 (p = 0.98) within the healthy controls.
Figure 1A illustrates the spatial map of highlighted brain
regions when the linked FA component was thresholded at
|Z|> 3.5, covering 55% of the forceps major tract. The group
mean of FA loadings was significantly lower in the patients with
schizophrenia (p = 8.51 × 10−9 ), as shown in Figure 1B, reflecting decreased FA in SZ patients in the forceps major. The same
direction of group mean for FA loadings (i.e., healthy controls
> patients with schizophrenia) was observed at all four sites,
thereby indicating no site by diagnosis interaction. We did not
observe any significant FA associations with patient symptoms
or chlorpromazine equivalent medication scores calculated from
all current medications, which is presented in Table 3. A recent
diffusion MRI study in schizophrenia reported an association
between visual hallucinations and the microstructure of forceps
major (Amad et al., 2013). Our dataset included 20 participants (i.e., within 73 Sz) who had a Global Rating of Severity of
Hallucinations (GR_Hallu) greater than three (Range being 0–5;
with five indicating most severe). On trying to replicate this however, we could not find any correlations between GR_Hallu and
the FA loadings in this complementary analysis, which could be
due to the very small sample size.
The linked SNP component depicted in Figure 1C also showed
significant group difference (p = 1.62 × 10−32 ) as expected, since
the SNPs for P-ICA were selected based on group difference. As
in Figure 1B, patients presented positive loadings while controls
presented negative loadings. This component was predominantly
contributed to by 326 SNPs (top 5% based on absolute values
of component weights). These SNPs, their host genes, z-scores
of component weight, original genotypic group difference and
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minor allele frequencies (MAFs) in patient and control groups
are indicated in Table S1. One hundred and sixty three SNPs
were mapped to 90 unique genes using SNPnexus (www.snpnexus.org), while the rest were from inter-genic regions. We also
examined the genetic architecture of our finding using Ingenuity
Pathway Analysis (IPA: https://www.ingenuity.com) where the 90
genes were compared with the whole genome as background.
IPA identified enrichment in abnormal morphology of corpus
callosum with gene hits in CNTNAP2, NFIB, and NPAS3 (p =
2.78 × 10−4 ), as illustrated in Table 4A. IPA also revealed a number of enriched canonical pathways, including synaptic long term
depression (LTD) (p = 8.71 × 10−4 ) and protein kinase A (PKA)
signaling (p = 1.02 × 10−3 ), as shown in Table 4B.
We also analyzed the FA-SNP pair obtained from the independent secondary P-ICA decomposition (i.e., considering caucasians participants), observing the FA component covered the
same region of forcep majors as obtained with the entire dataset.
The overlapping ratio of snps between SNP components (i.e.,
between caucasians only and the entire dataset P-ICA decompositions) was around 30%. Our previous studies have shown
that this overlap with such small sample size is much higher than
random (Chen et al., 2012a,b). We also observed a high correlation of -0.35 between the top paired FA and SNP loadings in this
caucasians only decomposition.

DISCUSSION
In this study we investigated the genetic underpinnings of white
matter abnormalities in SZ. A multivariate approach, P-ICA, was
used to extract SNP and FA components, and retrieve intermodality associations. Due to the limited sample size compared
to genome-wide SNPs, we preselected 6527 risk loci based upon
group difference to focus the FA-SNP association analysis on
polymorphisms likely relevant to SZ. This strategy could bias the
significance level of group difference in the SNP component, but
not the significance of identified FA-SNP correlations. Finally one
significant FA-SNP pair was identified with its validity confirmed
by the permutation test and 10-fold cross validation.
The identified FA component highlighted forceps major with
the loadings indicating lower FA-values in SZ than HC. Forceps
major fibers are located in the posterior end of the corpus callosum (CC), also known as splenium. These fibers interconnect
bilateral parietal and occipital (dorsal portion), as well as temporal cortices (ventral portion) (Park et al., 2008). There is a growing
body of evidence that FA is decreased in splenium for SZ patients
(Cheung et al., 2008; Gasparotti et al., 2009; Knoche et al., 2012;
Ellison-Wright et al., 2014), which has also been confirmed in
meta-analyses (Ellison-Wright and Bullmore, 2009; Patel et al.,
2011). Splenium was also identified to show decreased FA in an
ICA based study (Caprihan et al., 2011). Note that this local
FA reduction is observed in both chronic and non-medicated
first-episode patients, indicating a low possibility of medication
effect, consistent with no association being observed between the
FA loadings and the medication dosages in our study. Instead,
the lower FA may be a consequence of demyelination or axon
loss (Alexander et al., 2007), which coincides with the reports
of SZ-related reduction in volume of CC and the subregion of
splenium (Arnone et al., 2008; Francis et al., 2011). Additionally,
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FIGURE 1 | (A) FA component corresponding to Top P-ICA pair. (B)
Scatter plots of FA and SNP loadings (both SZ and HC participants)
from P-ICA with the regression line. The group mean directionality

Frontiers in Human Neuroscience

being HC > SZ. (C) Z-scored SNP component corresponding to Top
P-ICA pair. Horizontal lines indicate the threshold to obtain the top
5% SNPS.
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Table 3 | Summary of clinical information.
Number of Sz

% Reporting

DOI

% Reporting

PANSS

% Reporting

PANSS

% Reporting

duration of

Mean

(PANSS

positive

(PANSS

negative

medication

illness (DOI)

± SD

positive)

Mean ± SD

negative)

Mean ± SD

95.89

11.18 ± 10.5

97.26

15.94 ± 4.9

97.26

16.06 ± 4.9

73

Cpz eqvt of all
current
medications (mg/day)

91.78%

653.52 ± 684.14

Table 4 | Ingenuity pathway analysis on the SNP component.
p-Value

Molecules

A. DISEASES OR FUNCTIONS ANNOTATION
Abnormal morphology of brain

6.96E-03

CNTNAP2, FA2H, GRID2, LRRTM4, NPAS3, NFIB

Abnormal morphology of corpus callosum

2.78E-04

CNTNAP2, NPAS3, NFIB

Abnormal morphology of hippocampus

5.11E-03

LRRTM4, NPAS3, NFIB

Morphology of brain cells

6.59E-03

FA2H, GRID2, NFIB

B. CANONICAL PATHWAYS
Synaptic long term depression

8.71E-04

GRID2, RYR3, RYR2, PRKCB

Protein kinase A signaling

1.02E-03

PTPRD, RYR3, RYR2, CREB5, PTPRM, PRKCB

Gαs signaling

4.79E-03

RYR3, RYR2, CREB5

Hepatic cholestasis

8.71E-03

SLCO3A1, FABP6, PRKCB

CREB signaling in neurons

1.58E-02

GRID2, CREB5, PRKCB

Calcium signaling

1.74E-02

RYR3, RYR2, CREB5

family and twin studies suggest the FA reduction in splenium
and alterations in CC structure are likely regulated by genetics
(Pfefferbaum et al., 2001; Francis et al., 2011; Knoche et al., 2012).
Overall, the identified imaging component revealed a white matter biomarker robustly identified to characterize SZ while also
exhibiting heritability.
A negative FA-SNP correlation was observed; reflecting participants with SZ carrying higher loadings of specific genotypes
had lower FA-values in forceps major fibers. Corresponding to
the FA findings in splenium, the SNP component was overrepresented in networks affecting the abnormal morphology of corpus
callosum, involving CNTNAP2, NPAS3, and NFIB genes, as in
Table 4A. CNTNAP2 encodes a neurexin protein involved in neuron interaction and axon differentiation. SNPs in CNTNAP2 have
shown associations with FA in uncinated fasciculus (rs2710126)
(Clemm von Hohenberg et al., 2013) as well as graph measures
of structural brain connectivity including small-worldness and
global efficiency (rs2710102) (Dennis et al., 2011). A copy number variation disrupting CNTNAP2 is also suggested to play a role
in SZ (Friedman et al., 2008). The NPAS3-encoded protein regulates neurodevelopment (Sha et al., 2012) and NPAS3-deficient
mice exhibited hypoplasia of CC (Brunskill et al., 2005). Common
SNPs in NPAS3 have also been associated with SZ (Macintyre
et al., 2010). The transcription factor NFIB is demonstrated to
play a central role in the maturation of midline glia and formation
of CC in mouse studies (Piper et al., 2009). One speculation based
on our finding is that these identified SNPs affect white matter
integrity through regulating brain development, and SZ patients
tend to carry more risk genotypes for low white matter integrity.
The SNP component was also enriched in PKA signaling,
involving CREB, PRKCB, RYR2, RYR3, PTPRD, and PTPRM, as
in Table 4B. Cyclic AMP-dependent protein kinase (PKA) is an
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enzyme responsible for the phosphorylation of numerous nervous system proteins (Daniel et al., 1998), thus it is involved
in various mechanisms including axon guidance and myelination (Yoon et al., 2008; Murray et al., 2009). For instance, PKA
promotes the phosphorylation of CREB which regulates the
transcription of BDNF, a protein documented in neurogenesis,
axon guidance and synaptic plasticity (Cohen-Cory et al., 2010).
Indeed, CREB has a pivotal role in cellular processes and is
implicated in a wide spectrum of disorders including SZ (Yuan
et al., 2010; Saura and Valero, 2011). PRKCB encodes calciumdependent protein kinase (PKC) beta whose activity is shown
to modulate myelin gene expression in enriched oligodendrocytes (Asotra and Macklin, 1993) and mediate axon regeneration
(Sivasankaran et al., 2004). PKC beta is also observed to exhibit
disrupted expression in chronic SZ (Hakak et al., 2001). RYR2
and RYR3 encode ryanodine receptors serving as a calcium release
channel, thus they are involved in synaptic plasticity (Caillard
et al., 2000; Adasme et al., 2011) and functions in axon degeneration through mediating operations of GluR4 AMPA receptors
(Ouardouz et al., 2009). PTPRD and PTPRM encode receptor protein tyrosine phosphatases delta and mu which are significantly involved in neural development and axon guidance
(Ensslen-Craig and Brady-Kalnay, 2004). It is interesting to note
that, again the highlighted genes appear to converge on their
developmental roles.
Another significantly enriched pathway, LTD, involved GRID2
and three genes also participating in PKA signaling (RYR2, RYR3,
and PRKCB). GRID2 is a glutamate receptor known for its role
in synapse formation and LTD induction in cerebellum (Yuzaki,
2013). How it may relate to white matter integrity awaits further investigations. The other three genes, as reviewed above,
have been implicated in both axonogenesis and synaptic plasticity,

www.frontiersin.org

March 2015 | Volume 9 | Article 100 | 6

Gupta et al.

Genetic markers of white matter in schizophrenia

which is also documented for other genes (CREB, PTPRD, and
PTPRM) highlighted in the SNP component. While the SZ
neuropathology hypothesis based on altered brain connectivity
diverges in whether the dysconnection manifests anatomically
(through structural changes of association fibers) or functionally
(through aberrant control of synaptic plasticity), our observation suggested that these two factors might coexist (Stephan et al.,
2009). Despite that the FA-SNP association indicated these genes
contributing to structural dysconnectivity, their potential role in
abnormal synaptic regulation cannot be ruled out and deserves
further delineation.
The current study was limited in the following aspects. First,
the imaging data were collected at multiple sites with different platforms. To address the potentially confounding site effect,
we performed a voxelwise regression to eliminate the related
effects and used the corrected data for P-ICA. Another limitation lied in the admission of subjects with various ethnicities.
To avoid biased findings, we corrected the SNP data by eliminating the ethnicity-related components. In the resulting FA-SNP
association, we did not observe any significant contribution from
ethnicity. Meanwhile, due to the limited sample size, the investigation of FA-SNP associations focused on 6527 pre-filtered SNPs,
which is likely incomplete given the complex mechanisms underlying white matter abnormalities. Our finding depicts a part of
the picture. The observed SNP-FA association appeared to be
mainly driven by the group difference, given that no significant correlation was observed in either patient or control group.
Specifically for the patient group, we included medication (i.e.,
chlorpromazine equivalents of current medication) in the regression model and did not observe any significant effect on the FA
loadings. Exploring further we found that the top paired SNP
component from P-ICA was found to be the second most significant component showing group difference, replicating reliably
in all subset evaluations. This could indicate the uniqueness in
FA-SNP component association other than the shared group difference, bringing forth the fact that FA changes are likely due to
genetic factors. However, other factors cannot be completely ruled
out in this work. Though premature, we might speculate that the
FA-SNP relationship is limited by the range of symptom severity
measures. The range for PANSS positive and negative symptoms
is 0–49 (Opler et al., 2006) and from Table 3 we observe that this
dataset could represent a population occupying a very narrow
slice of the schizophrenia spectrum. The association therefore,
might get stronger in a dataset that is more strongly psychotic.
Also, the unavailability of an independent dataset for replication
of results is a limitation, though we ascertained this to a certain
extent using 10-fold validation and permutation tests. FA-SNP
association presented here is the first step and future work will
involve investigation of complementary indices like axial diffusivity and radial diffusivity, for association with genetic data. We
chose the FA approach as it enables a full characterization of
multivariate distribution of values. Future work may also focus
on the use of Tract Based Spatial Statistics, which provides a
much smaller set of values and removes data in a complex and
non-linear manner.
In conclusion, we consider this work one step further
toward understanding the genetic underpinnings of white matter
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abnormalities in SZ, in part as it assessed multiple genetic variants
for aggregate effects. More importantly, we revealed that this local
FA reduction was associated with a genetic factor enriched in CC
morphology, LTD and PKA signaling. The involved genes appear
to converge on developmental functions, indicating a possibility that genetic variants contribute to white matter abnormalities
through disrupting neural development. The fact that these genes
also participate in synaptic plasticity leads to the speculation of
functional dysconnectivity, which will be investigated in a future
study.

ACKNOWLEDGMENTS
This work was funded by the following NIH grants
1R01MH094524,
1RC1MH089257,
R01EB005846,
and
5P20RR021938/5P20GM103472.

SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://www.frontiersin.org/journal/10.3389/fnhum.
2015.00100/abstract

REFERENCES
Adasme, T., Haeger, P., Paula-Lima, A. C., Espinoza, I., Casas-Alarcon, M.
M., Carrasco, M. A., et al. (2011). Involvement of ryanodine receptors in neurotrophin-induced hippocampal synaptic plasticity and spatial
memory formation. Proc. Natl. Acad. Sci. U.S.A. 108, 3029–3034. doi:
10.1073/pnas.1013580108
Alexander, A. L., Lee, J. E., Lazar, M., and Field, A. S. (2007). Diffusion tensor imaging of the brain. Neurotherapeutics 4, 316–329. doi: 10.1016/j.nurt.2007.05.011
Amad, A., Cachia, A., Gorwood, P., Pins, D., Delmaire, C., Rolland, B., et al. (2013).
The multimodal connectivity of the hippocampal complex in auditory and
visual hallucinations. Mol. psychiatry 19, 184–191. doi: 10.1038/mp.2012.181
Anderson, C. A., Pettersson, F. H., Clarke, G. M., Cardon, L. R., Morris, A. P., and
Zondervan, K. T. (2010). Data quality control in genetic case-control association
studies. Nat. protoc. 5, 1564–1573. doi: 10.1038/nprot.2010.116
Arnone, D., McIntosh, A. M., Tan, G. M. Y., and Ebmeier, K. P. (2008). Metaanalysis of magnetic resonance imaging studies of the corpus callosum in
schizophrenia. Schizophr. Res. 101, 124–132. doi: 10.1016/j.schres.2008.01.005
Asotra, K., and Macklin, W. B. (1993). Protein-Kinase-C activity modulates myelin
gene-expression in enriched oligodendrocytes. J. Neurosci. Res. 34, 571–588. doi:
10.1002/jnr.490340509
Bell, A. J., and Sejnowski, T. J. (1995). An information-maximization approach to
blind separation and blind deconvolution. Neural comput. 7, 1129–1159. doi:
10.1162/neco.1995.7.6.1129
Brunskill, E. W., Ehrman, L. A., Williams, M. T., Klanke, J., Hammer, D., Schaefer,
T. L., et al. (2005). Abnormal neurodevelopment, neurosignaling and behaviour
in Npas3-deficient mice. Eur. J. Neurosci. 22, 1265–1276. doi: 10.1111/j.14609568.2005.04291.x
Caillard, O., Ben-Ari, Y., and Gaiarsa, J. L. (2000). Activation of presynaptic and
postsynaptic ryanodine-sensitive calcium stores is required for the induction of
long-term depression at GABAergic synapses in the neonatal rat hippocampus.
J. Neurosci. 20, 91–95.
Caprihan, A., Abbott, C., Yamamoto, J., Pearlson, G., Perrone-Bizzozero, N.,
Sui, J., et al. (2011). Source-based morphometry analysis of group differences in fractional anisotropy in schizophrenia. Brain connect. 1, 133–145. doi:
10.1089/brain.2011.0015
Chen, J., Calhoun, V. D., and Liu, J. (2012a). ICA order selection based on consistency: application to genotype data. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2012,
360–363. doi: 10.1109/EMBC.2012.6345943
Chen, J., Calhoun, V. D., Pearlson, G. D., Ehrlich, S., Turner, J. A., Ho, B.-C.,
et al. (2012b). Multifaceted genomic risk for brain function in schizophrenia.
Neuroimage 61, 866–875. doi: 10.1016/j.neuroimage.2012.03.022
Cheung, V., Cheung, C., McAlonan, G. M., Deng, Y., Wong, J. G., Yip, L., et al.
(2008). A diffusion tensor imaging study of structural dysconnectivity in

www.frontiersin.org

March 2015 | Volume 9 | Article 100 | 7

Gupta et al.

Genetic markers of white matter in schizophrenia

never-medicated, first-episode schizophrenia. Psychol. Med. 38, 877–885. doi:
10.1017/S0033291707001808
Clark, K. A., Nuechterlein, K. H., Asarnow, R. F., Hamilton, L. S., Phillips, O. R.,
Hageman, N. S., et al. (2011). Mean diffusivity and fractional anisotropy as
indicators of disease and genetic liability to schizophrenia. J. Psychiatr. Res. 45,
980–988. doi: 10.1016/j.jpsychires.2011.01.006
Clemm von Hohenberg, C., Wigand, M. C., Kubicki, M., Leicht, G., Giegling, I.,
Karch, S., et al. (2013). CNTNAP2 polymorphisms and structural brain connectivity: a diffusion-tensor imaging study. J. Psychiatr. Res. 47, 1349–1356. doi:
10.1016/j.jpsychires.2013.07.002
Cohen-Cory, S., Kidane, A. H., Shirkey, N. J., and Marshak, S. (2010). Brain-derived
neurotrophic factor and the development of structural neuronal connectivity.
Dev. Neurobiol. 70, 271–288. doi: 10.1002/dneu.20774
Daniel, P. B., Walker, W. H., and Habener, J. F. (1998). Cyclic AMP
signaling and gene regulation. Annu. Rev. Nutr. 18, 353–383. doi:
10.1146/annurev.nutr.18.1.353
Dennis, E. L., Jahanshad, N., Rudie, J. D., Brown, J. A., Johnson, K., McMahon,
K. L., et al. (2011). Altered structural brain connectivity in healthy carriers of the autism risk gene, CNTNAP2. Brain Connect. 1, 447–459. doi:
10.1089/brain.2011.0064
Ellison-Wright, I., and Bullmore, E. (2009). Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophr. Res. 108, 3–10. doi:
10.1016/j.schres.2008.11.021
Ellison-Wright, I., Nathan, P. J., Bullmore, E. T., Zaman, R., Dudas, R. B., Agius,
M., et al. (2014). Distribution of tract deficits in schizophrenia. BMC Psychiatry
14:99. doi: 10.1186/1471-244X-14-99
Ensslen-Craig, S. E., and Brady-Kalnay, S. M. (2004). Receptor protein tyrosine
phosphatases regulate neural development and axon guidance. Dev. Biol. 275,
12–22. doi: 10.1016/j.ydbio.2004.08.009
Francis, A. N., Bhojraj, T. S., Prasad, K. M., Kulkarni, S., Montrose, D. M., Eack,
S. M., et al. (2011). Abnormalities of the corpus callosum in non-psychotic
high-risk offspring of schizophrenia patients. Psychiatry Res. 191, 9–15. doi:
10.1016/j.pscychresns.2010.09.007
Friedman, J. I., Vrijenhoek, T., Markx, S., Janssen, I. M., van der Vliet, W. A., Faas, B.
H., et al. (2008). CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol. Psychiatry 13, 261–266. doi: 10.1038/sj.mp.4002049
Gasparotti, R., Valsecchi, P., Carletti, F., Galluzzo, A., Liserre, R., Cesana, B.,
et al. (2009). Reduced fractional anisotropy of corpus callosum in firstcontact, antipsychotic drug-naive patients with schizophrenia. Schizophr. Res.
108, 41–48. doi: 10.1016/j.schres.2008.11.015
Gejman, P. V., Sanders, A. R., and Kendler, K. S. (2011). Genetics of schizophrenia:
new findings and challenges. Annu. Rev. Genomics Hum. Genet. 12, 121–144.
doi: 10.1146/annurev-genom-082410-101459
Giusti-Rodriguez, P., and Sullivan, P. F. (2013). The genomics of schizophrenia:
update and implications. J. Clin. Invest. 123, 4557–4563. doi: 10.1172/JCI66031
Gollub, R. L., Shoemaker, J. M., King, M. D., White, T., Ehrlich, S.,
Sponheim, S. R., et al. (2013). The MCIC collection: a shared repository
of multi-modal, multi-site brain image data from a clinical investigation
of schizophrenia. Neuroinformatics 11, 367–388. doi: 10.1007/s12021-0139184-3
Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., et al.
(2001). Genome-wide expression analysis reveals dysregulation of myelinationrelated genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 98,
4746–4751. doi: 10.1073/pnas.081071198
Hoptman, M. J., Nierenberg, J., Bertisch, H. C., Catalano, D., Ardekani, B. A.,
Branch, C. A., et al. (2008). A DTI study of white matter microstructure in individuals at high genetic risk for schizophrenia. Schizophr. Res. 106, 115–124. doi:
10.1016/j.schres.2008.07.023
Jones, D. K., Symms, M. R., Cercignani, M., and Howard, R. J. (2005). The effect
of filter size on VBM analyses of DT-MRI data. Neuroimage 26, 546–554. doi:
10.1016/j.neuroimage.2005.02.013
Knoche, C., Oertel-Knochel, V., Schonmeyer, R., Rotarska-Jagiela, A., van de
Ven, V., Prvulovic, D., et al. (2012). Interhemispheric hypoconnectivity in
schizophrenia: Fiber integrity and volume differences of the corpus callosum in patients and unaffected relatives. Neuroimage 59, 926–934. doi:
10.1016/j.neuroimage.2011.07.088
Kubicki, M., McCarley, R., Westin, C. F., Park, H. J., Maier, S., Kikinis, R.,
et al. (2007). A review of diffusion tensor imaging studies in schizophrenia.
J. Psychiatr. Res. 41, 15–30. doi: 10.1016/j.jpsychires.2005.05.005

Frontiers in Human Neuroscience

Lee, S. H., DeCandia, T. R., Ripke, S., Yang, J. C., Schizophrenia Psychiatric
Genome-Wide Association Study, C. International Schizophrenia, et al.
(2012). Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat. Genet. 44, 247–250. doi: 10.1038/
ng.1108
Liu, J., Bixler, J. N., and Calhoun, V. D. (2008). “A multimodality ICA study –
integrating genomic single nucleotide polymorphisms with functional neuroimaging data,” in 2008 IEEE International Conference on Bioinformatics and
Biomedicine Workshops, (Philadelphia, PA).
Liu, J., and Calhoun, V. D. (2014). A review of multivariate analyses in imaging
genetics. Front. Neuroinform. 8:29. doi: 10.3389/fninf.2014.00029
Liu, J. Y., Pearlson, G., Windemuth, A., Ruano, G., Perrone-Bizzozero, N. I., and
Calhoun, V. (2009). Combining fMRI and SNP data to investigate connections
between brain function and genetics using parallel ICA. Hum. Brain Mapp. 30,
241–255. doi: 10.1002/hbm.20508
Macintyre, G., Alford, T., Xiong, L., Rouleau, G. A., Tibbo, P. G., and Cox, D. W.
(2010). Association of NPAS3 exonic variation with schizophrenia. Schizophr.
Res. 120, 143–149. doi: 10.1016/j.schres.2010.04.002
Maniega, S. M., Lymer, G. K. S., Bastin, M. E., Marjoram, D., Job, D. E., Moorhead,
T. W. J., et al. (2008). A diffusion tensor MRI study of white matter integrity in
subjects at high genetic risk of schizophrenia. Schizophr. Res. 106, 132–139. doi:
10.1016/j.schres.2008.09.016
Murray, A. J., Tucker, S. J., and Shewan, D. A. (2009). cAMP-dependent axon
guidance is distinctly regulated by Epac and protein kinase A. J. Neurosci. 29,
15434–15444. doi: 10.1523/JNEUROSCI.3071-09.2009
Opler, L., Opler, M., and Malaspina, D. (2006). Reducing guesswork in schizophrenia treatment PANSS can target and gauge therapy, predict outcomes in clinical
practice. Curr. Psychiatr. 5, 76.
Ouardouz, M., Coderre, E., Zamponi, G. W., Hameed, S., Yin, X. H., Trapp, B. D.,
et al. (2009). Glutamate receptors on myelinated spinal cord axons: II. AMPA
and GluR5 receptors. Ann. Neurol. 65, 160–166. doi: 10.1002/ana.21539
Park, H. J., Kim, J. J., Lee, S. K., Seok, J. H., Chun, J., Kim, D. I., et al. (2008).
Corpus callosal connection mapping using cortical gray matter parcellation and
DT-MRI. Hum. Brain Mapp. 29, 503–516. doi: 10.1002/hbm.20314
Patel, S., Mahon, K., Wellington, R., Zhang, J. P., Chaplin, W., and Szeszko,
P. R. (2011). A meta-analysis of diffusion tensor imaging studies of
the corpus callosum in schizophrenia. Schizophr. Res. 129, 149–155. doi:
10.1016/j.schres.2011.03.014
Pfefferbaum, A., Sullivan, E. V., and Carmelli, D. (2001). Genetic regulation of
regional microstructure of the corpus callosum in late life. Neuroreport 12,
1677–1681. doi: 10.1097/00001756-200106130-00032
Piper, M., Moldrich, R. X., Lindwall, C., Little, E., Barry, G., Mason, S., et al. (2009).
Multiple non-cell-autonomous defects underlie neocortical callosal dysgenesis
in Nfib-deficient mice. Neural Dev. 4:43. doi: 10.1186/1749-8104-4-43
Purcell, S. M., Moran, J. L., Fromer, M., Ruderfer, D., Solovieff, N., Roussos, P.,
et al. (2014). A polygenic burden of rare disruptive mutations in schizophrenia.
Nature 506, 185–190. doi: 10.1038/nature12975
Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O’Donovan, M. C.,
Sullivan, P. F., et al. (2009). Common polygenic variation contributes to risk
of schizophrenia and bipolar disorder. Nature 460, 748–752.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A., Bender, D., et al.
(2007). PLINK: a tool set for whole-genome association and population-based
linkage analyses. Am. J. Hum. Genet. 81, 559–575. doi: 10.1086/519795
Rissanen, J. (1978). Modeling by shortest data description. Automatica 14, 465–471.
doi: 10.1016/0005-1098(78)90005-5
Rose, E. J., and Donohoe, G. (2013). Brain vs behavior: an effect size comparison of
neuroimaging and cognitive studies of genetic risk for schizophrenia. Schizophr.
Bull. 39, 518–526. doi: 10.1093/schbul/sbs056
Saura, C. A., and Valero, J. (2011). The role of CREB signaling in Alzheimer’s
disease and other cognitive disorders. Rev. Neurosci. 22, 153–169. doi:
10.1515/rns.2011.018
Sha, L., MacIntyre, L., Machell, J. A., Kelly, M. P., Porteous, D. J., Brandon,
N. J., et al. (2012). Transcriptional regulation of neurodevelopmental and
metabolic pathways by NPAS3. Mol. Psychiatry 17, 267–279. doi: 10.1038/mp.
2011.73
Sivasankaran, R., Pei, J., Wang, K. C., Zhang, Y. P., Shields, C. B., Xu, X. M.,
et al. (2004). PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration. Nat. Neurosci. 7, 261–268. doi:
10.1038/nn1193

www.frontiersin.org

March 2015 | Volume 9 | Article 100 | 8

Gupta et al.

Genetic markers of white matter in schizophrenia

Stephan, K. E., Friston, K. J., and Frith, C. D. (2009). Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr.
Bull. 35, 509–527. doi: 10.1093/schbul/sbn176
Sullivan, P. F., Kendler, K. S., and Neale, M. C. (2003). Schizophrenia as a complex
trait – evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 60,
1187–1192. doi: 10.1001/archpsyc.60.12.1187
Visscher, P. M., Brown, M. A., McCarthy, M. I., and Yang, J. (2012). Five years of
GWAS discovery. Am. J. Hum. Genet. 90, 7–24. doi: 10.1016/j.ajhg.2011.11.029
White, T., Magnotta, V. A., Bockholt, H. J., Williams, S., Wallace, S., Ehrlich,
S., et al. (2011). Global white matter abnormalities in schizophrenia: a
multisite diffusion tensor imaging study. Schizophr. Bull. 37, 222–232. doi:
10.1093/schbul/sbp088
Williams, J. B. W., Gibbon, M., First, M. B., Spitzer, R. L., Davies, M., Borus,
J., et al. (1992). The structured clinical interview for DSM-III-R (SCID) II.
Multisite test-retest reliability. Arch. Gen. psychiatry 49, 630. doi: 10.1001/archpsyc.1992.01820080038006
Yoon, C., Korade, Z., and Carter, B. D. (2008). Protein kinase a-induced phosphorylation of the p65 subunit of nuclear factor-kappa B promotes Schwann cell
differentiation into a myelinating phenotype. J. Neurosci. 28, 3738–3746. doi:
10.1523/JNEUROSCI.4439-07.2008
Yuan, P. X., Zhou, R. L., Wang, Y., Li, X. X., Li, J. L., Chen, G., et al. (2010). Altered
levels of extracellular signal-regulated kinase signaling proteins in postmortem

Frontiers in Human Neuroscience

frontal cortex of individuals with mood disorders and schizophrenia. J. Affect.
Disord. 124, 164–169. doi: 10.1016/j.jad.2009.10.017
Yuzaki, M. (2013). Cerebellar LTD vs. motor learning-lessons learned from
studying GluD2. Neural Netw. 47, 36–41. doi: 10.1016/j.neunet.2012.07.001
Conflict of Interest Statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 26 July 2014; accepted: 10 February 2015; published online: 03 March 2015.
Citation: Gupta CN, Chen J, Liu J, Damaraju E, Wright C, Perrone-Bizzozero NI,
Pearlson G, Luo L, Michael AM, Turner JA and Calhoun VD (2015) Genetic markers of white matter integrity in schizophrenia revealed by parallel ICA. Front. Hum.
Neurosci. 9:100. doi: 10.3389/fnhum.2015.00100
This article was submitted to the journal Frontiers in Human Neuroscience.
Copyright © 2015 Gupta, Chen, Liu, Damaraju, Wright, Perrone-Bizzozero,
Pearlson, Luo, Michael, Turner and Calhoun. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s)
or licensor are credited and that the original publication in this journal is cited, in
accordance with accepted academic practice. No use, distribution or reproduction is
permitted which does not comply with these terms.

www.frontiersin.org

March 2015 | Volume 9 | Article 100 | 9

